IL-4 Receptor-alpha-dependent control of Cryptococcus neoformans in the early phase of pulmonary infection

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Grahnert, Andreas ^a   Richter, Tina ^a   Piehler, Daniel ^a   Eschke, Maria ^a   Schulze, Bianca ^a   Müller, Uwe ^a   Protschka, Martina ^a   Köhler, Gabriele ^b   Sabat, Robert ^c   Brombacher, Frank ^d   Alber, Gottfried ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4 RECEPTOR ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHILIA; FEMALE; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGEN LOAD; PULMONARY CRYPTOCOCCOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELLS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA; SIGNAL TRANSDUCTION;

EID: 84900329695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087341     Document Type: Article

References (59)

1. Feldmesser M, Tucker S, Casadevall A (2001) Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 9: 273-278. (Pubitemid 32522807)
2. Charlier C, Dromer F, Leveque C, Chartier L, Cordoliani YS, et al. (2008) Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One 3: e1950-
3. Husain S, Wagener MM, Singh N (2001) Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 7: 375-381.
4. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, et al. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
5. Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB, et al. (2005) Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 174: 1027-1036. (Pubitemid 40094299)
6. Jain AV, Zhang Y, Fields WB, McNamara DA, Choe MY, et al. (2009) Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection. Infect Immun 77: 5389-5399.
7. Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, et al. (2005) Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J Immunol 174: 6346-6356. (Pubitemid 40663828)
8. Chen GH, Olszewski MA, McDonald RA, Wells JC, Paine R III, et al. (2007) Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol 170: 1028-1040. (Pubitemid 47339370)
9. Brombacher F (2000) The role of interleukin-13 in infectious diseases and allergy. Bioessays 22: 646-656.
10. Chatila TA (2004) Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med 10: 493-499.
11. Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M (2010) Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 184: 1663-1674.
12. Hoag KA, Lipscomb MF, Izzo AA, Street NE (1997) IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 17: 733-739. (Pubitemid 127348664)
13. Hoag KA, Street NE, Huffnagle GB, Lipscomb MF (1995) Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 13: 487-495.
14. Decken K, Kohler G, Palmer-Lehmann K, Wunderlin A, Mattner F, et al. (1998) Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 66: 4994-5000. (Pubitemid 28453112)
15. Kawakami K, Tohyama M, Qifeng X, Saito A (1997) Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Immun 65: 1307-1312. (Pubitemid 27146617)
16. Blackstock R, Murphy JW (2004) Role of interleukin-4 in resistance to Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 30: 109-117. (Pubitemid 38085265)
17. Kawakami K, Hossain QM, Zhang T, Koguchi Y, Xie Q, et al. (1999) Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines. Cell Immunol 197: 55-61.
18. Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, et al. (2001) IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol 2: 1054-1060. (Pubitemid 33069501)
19. Mencacci A, Del SG, Cenci E, d'Ostiani CF, Bacci A, et al. (1998) Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med 187: 307-317. (Pubitemid 28080060)
20. Suzuki Y, Yang Q, Yang S, Nguyen N, Lim S, et al. (1996) IL-4 is protective against development of toxoplasmic encephalitis. J Immunol 157: 2564-2569. (Pubitemid 126450470)
21. Hochrein H, O'Keeffe M, Luft T, Vandenabeele S, Grumont RJ, et al. (2000) Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 192: 823-833.
22. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G (1995) Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 181: 537-546.
23. Yao Y, Li W, Kaplan MH, Chang CH (2005) Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 201: 1899-1903. (Pubitemid 41002926)
24. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, et al. (1996) Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A 93: 497-501. (Pubitemid 26038184)
25. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, et al. (1996) cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 271: 29265-29270. (Pubitemid 26382639)
26. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, et al. (1996) Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 271: 16921-16926. (Pubitemid 26239062)
27. Junttila IS, Mizukami K, Dickensheets H, Meier-Schellersheim M, Yamane H, et al. (2008) Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity. J Exp Med 205: 2595-2608.
28. Mohrs M, Ledermann B, Kohler G, Dorfmuller A, Gessner A, et al. (1999) Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol 162: 7302-7308. (Pubitemid 29277704)
29. Muller U, Stenzel W, Kohler G, Werner C, Polte T, et al. (2007) IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 179: 5367-5377.
30. Stevens WW, Kim TS, Pujanauski LM, Hao X, Braciale TJ (2007) Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J Immunol Methods 327: 63-74. (Pubitemid 47444310)
31. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36: 1309-1323.
32. Wolk K, Witte E, Hoffmann U, Doecke WD, Endesfelder S, et al. (2007) IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol 178: 5973-5981. (Pubitemid 46674395)
33. Piehler D, Grahnert A, Eschke M, Richter T, Kohler G, et al. (2013) T1/ST2 promotes T helper 2 cell activation and polyfunctionality in bronchopulmonary mycosis. Mucosal Immunol 6: 405-414.
34. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92. (Pubitemid 29096240)
35. Velagapudi R, Hsueh YP, Geunes-Boyer S, Wright JR, Heitman J (2009) Spores as infectious propagules of Cryptococcus neoformans. Infect Immun 77: 4345-4355.
36. Muller U, Stenzel W, Kohler G, Polte T, Blessing M, et al. (2008) A gene-dosage effect for interleukin-4 receptor alpha-chain expression has an impact on Th2-mediated allergic inflammation during bronchopulmonary mycosis. J Infect Dis 198: 1714-1721.
37. Muller U, Piehler D, Stenzel W, Kohler G, Frey O, et al. (2012) Lack of IL-4 receptor expression on T helper cells reduces T helper 2 cell polyfunctionality and confers resistance in allergic bronchopulmonary mycosis. Mucosal Immunol 5: 299-310.
38. Muller U, Stenzel W, Piehler D, Grahnert A, Protschka M, et al. (2013) Abrogation of IL-4 receptor-alpha-dependent alternatively activated macrophages is sufficient to confer resistance against pulmonary cryptococcosis despite an ongoing Th2 response. Int Immunol
39. Huffnagle GB, Boyd MB, Street NE, Lipscomb MF (1998) IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J Immunol 160: 2393-2400. (Pubitemid 28119923)
40. Goldman DL, Davis J, Bommarito F, Shao X, Casadevall A (2006) Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma. J Infect Dis 193: 1178-1186.
41. Gunn MD, Nelken NA, Liao X, Williams LT (1997) Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 158: 376-383. (Pubitemid 127483879)
42. Kallal LE, Schaller MA, Lindell DM, Lira SA, Lukacs NW (2010) CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. Eur J Immunol 40: 1042-1052.
43. MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15:323-50.: 323-350.
44. Kawakami K, Qureshi MH, Zhang T, Koguchi Y, Shibuya K, et al. (1999) Interferon-gamma (IFN-gamma)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans. Clin Exp Immunol 117: 113-122. (Pubitemid 29292786)
45. Osterholzer JJ, Chen GH, Olszewski MA, Curtis JL, Huffnagle GB, et al. (2009) Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol 183: 8044-8053.
46. Alspaugh JA, Granger DL (1991) Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun 59: 2291-2296.
47. Lee SC, Dickson DW, Brosnan CF, Casadevall A (1994) Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 180: 365-369.
48. Aguirre KM, Gibson GW (2000) Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection. Med Mycol 38: 343-353.
49. Pietrella D, Corbucci C, Perito S, Bistoni G, Vecchiarelli A (2005) Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation. Infect Immun 73: 820-827. (Pubitemid 40165738)
50. Wozniak KL, Levitz SM (2008) Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun 76: 4764-4771.
51. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17:701-38.: 701-738.
52. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989) Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169: 59-72. (Pubitemid 19035542)
53. Locksley RM, Heinzel FP, Holaday BJ, Mutha SS, Reiner SL, et al. (1991) Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. Res Immunol 142: 28-32.
54. Lutz MB, Schnare M, Menges M, Rossner S, Rollinghoff M, et al. (2002) Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J Immunol 169: 3574-3580.
55. Newcomb DC, Zhou W, Moore ML, Goleniewska K, Hershey GK, et al. (2009) A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production. J Immunol 182: 5317-5321.
56. Alexander J, McFarlane E (2008) Can type-1 responses against intracellular pathogens be T helper 2 cytokine dependent? Microbes Infect 10: 953-959.
57. Flesch IE, Wandersee A, Kaufmann SH (1997) Effects of IL-13 on murine listeriosis. Int Immunol 9: 467-474. (Pubitemid 27168479)
58. Webb DC, Cai Y, Matthaei KI, Foster PS (2007) Comparative roles of IL-4, IL-13, and IL-4Ralpha in dendritic cell maturation and CD4+ Th2 cell function. J Immunol 178: 219-227. (Pubitemid 46033604)
59. Stager S, Alexander J, Carter KC, Brombacher F, Kaye PM (2003) Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Infect Immun 71: 4804-4807. (Pubitemid 36919951)